DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0700095 | Central neuroblastoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0021400 | Influenza | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C1306459 | Primary malignant neoplasm | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C4048328 | cervical cancer | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0302592 | Cervix carcinoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0027819 | Neuroblastoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0343641 | Human papilloma virus infection | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0018213 | Graves Disease | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0265221 | Walker-Warburg congenital muscular dystrophy | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0036341 | Schizophrenia | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0027651 | Neoplasms | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0027051 | Myocardial Infarction | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0376358 | Malignant neoplasm of prostate | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0033860 | Psoriasis | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0007138 | Carcinoma, Transitional Cell | B3GNT2 | 10678 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q9NY97 |
C0009402 | Colorectal Carcinoma | UGT3A2 | 167127 | UDP glycosyltransferase family 3 member A2 | Q3SY77 |
C0027651 | Neoplasms | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C0265554 | Ectrodactyly | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C0235974 | Pancreatic carcinoma | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C0751396 | Well Differentiated Oligodendroglioma | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C0006142 | Malignant neoplasm of breast | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C0035222 | Respiratory Distress Syndrome, Adult | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C0027126 | Myotonic Dystrophy | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C0006826 | Malignant Neoplasms | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C2931019 | Split hand foot deformity 1 | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024